Simon Lu
Directeur/Bestuurslid bij ASCENTAGE PHARMA GROUP INTERNATIONAL
Vermogen: - $ op 31-05-2024
Profiel
Simon Dazhong Lu is a Non-Executive Director at Ascentage Pharma Group International Co., Ltd.
He was previously a Director at McGill University, Managing Director at CEL Partners Co. Ltd., and Partner & Investment Manager at Shanghai NewMargin Ventures Investment Management Co. Ltd.
He also worked as an Auditor at Arthur Andersen Business Consulting Co. Ltd.
(Shanghai).
Lu holds a doctorate degree from Nankai University, which he received in 2010, and an undergraduate degree from the same university, which he received in 1991.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 31-12-2023 | 0 ( -.--% ) | - $ | 31-05-2024 |
Actieve functies van Simon Lu
| Bedrijven | Functie | Begin |
|---|---|---|
| ASCENTAGE PHARMA GROUP INTERNATIONAL | Directeur/Bestuurslid | 06-07-2018 |
Eerdere bekende functies van Simon Lu
| Bedrijven | Functie | Einde |
|---|---|---|
| McGill University | Directeur/Bestuurslid | 01-11-2018 |
CEL Partners Co. Ltd.
 CEL Partners Co. Ltd. Investment ManagersFinance CEL Partners is an independent China-based private equity firm which was established in 2007 to manage China Equity Links SAS, the first independent continental Europe private equity fund dedicated to investments in China. Based in Beijing, CEL Partners is comprised of Chinese and Western professionals, complemented by a team of Senior Advisors. The China Equity Links fund is backed by global financial institutions including Crédit Agricole, Société Générale, Caisse des Dépôt et des Consignations, Savings Bank Group, CNP, Groupama and Scor and has an office in Paris, France. | Algemeen Directeur | 01-07-2009 |
Shanghai NewMargin Ventures Investment Management Co. Ltd.
 Shanghai NewMargin Ventures Investment Management Co. Ltd. Investment ManagersFinance Shanghai NewMargin Ventures Investment Management Co. Ltd. is an Independent Venture Capital firm founded in 1999 by Tao Feng. Shanghai NewMargin Ventures Investment Management Co. Ltd. is headquartered in Shanghai. | Chief Investment Officer | 01-12-2007 |
| Arthur Andersen Business Consulting Co. Ltd. (Shanghai) | Comptroller/Controller/Auditor | - |
Opleiding van Simon Lu
| Nankai University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ASCENTAGE PHARMA GROUP INTERNATIONAL | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Shanghai NewMargin Ventures Investment Management Co. Ltd.
Shanghai NewMargin Ventures Investment Management Co. Ltd. Investment ManagersFinance Shanghai NewMargin Ventures Investment Management Co. Ltd. is an Independent Venture Capital firm founded in 1999 by Tao Feng. Shanghai NewMargin Ventures Investment Management Co. Ltd. is headquartered in Shanghai. | Finance |
CEL Partners Co. Ltd.
CEL Partners Co. Ltd. Investment ManagersFinance CEL Partners is an independent China-based private equity firm which was established in 2007 to manage China Equity Links SAS, the first independent continental Europe private equity fund dedicated to investments in China. Based in Beijing, CEL Partners is comprised of Chinese and Western professionals, complemented by a team of Senior Advisors. The China Equity Links fund is backed by global financial institutions including Crédit Agricole, Société Générale, Caisse des Dépôt et des Consignations, Savings Bank Group, CNP, Groupama and Scor and has an office in Paris, France. | Finance |
| Arthur Andersen Business Consulting Co. Ltd. (Shanghai) |
